| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |